Osteopore (OSX.AX)

Osteopore Limited is a medical device company based in Singapore and listed on the Australian Stock Exchange. The company specializes in the design, development, and marketing of bioresorbable polymer implants primarily used in neurosurgical, orthopedic, and maxillofacial surgery. Osteopore is recognized for its advanced technologies in tissue engineering, regenerative medicine, and 3D printing, which enable the creation of implants that support natural bone healing and regeneration. The company's proprietary technology produces synthetic biologically active tissue-engineered scaffolds that allow patients' own bone cells to regenerate, effectively restoring the skeleton. These implants dissolve over time, leaving behind healthy bone and reducing post-surgical complications. Osteopore's products are approved for use in over 20 countries and have been successfully utilized in more than 100,000 cases globally, including pioneering surgeries in skull, long bone, and jawbone reconstructions. The company adheres to strict quality standards, ensuring compliance with global regulatory requirements for medical devices.

• Employees 23
• Founded 1992
• Annual Revenue $1747000
• Total Funding $360000